Alder Biopharmaceuticals Inc (ALDR:NASDAQ) Investor Relations Material

Overview

Alder Biopharmaceuticals is a biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutic antibodies that have the potential to revolutionize current treatment practices. They have developed an innovative antibody platform that aims to identify antibodies with maximum efficacy, a quick response rate, and sustainable therapeutic benefits. The company is currently operating at a clinical stage, with plans to move forward in transforming healthcare.

Frequently Asked Questions

What is Alder Biopharmaceuticals Inc's ticker?

Alder Biopharmaceuticals Inc's ticker is ALDR

What exchange is Alder Biopharmaceuticals Inc traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Alder Biopharmaceuticals Inc's headquarters?

They are based in South Bothell, Washington

How many employees does Alder Biopharmaceuticals Inc have?

There are 201-500 employees working at Alder Biopharmaceuticals Inc

What is Alder Biopharmaceuticals Inc's website?

It is http://www.alderbio.com/

What type of sector is Alder Biopharmaceuticals Inc?

Alder Biopharmaceuticals Inc is in the Healthcare sector

What type of industry is Alder Biopharmaceuticals Inc?

Alder Biopharmaceuticals Inc is in the Biotechnology industry

Who are Alder Biopharmaceuticals Inc's peers and competitors?

The following five companies are Alder Biopharmaceuticals Inc's industry peers:

- Puma Biotechnology

- Achieve Life Sciences

- Ultragenyx Pharmaceutical

- AVROBIO, Inc.

- AdAlta